<DOC>
	<DOC>NCT00824928</DOC>
	<brief_summary>To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term efficacy and safety of this procedure. Ultimately the data analysis will serve as a robust guidance instrument for improving upon the utilization of this procedure for the treatment of patients with recurrent (LRD) prostate cancer.</brief_summary>
	<brief_title>Salvage Cryotherapy in Recurrent Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Read &amp; understand informed consent related to this study including consenting and HIPPA authorization Undergone salvage cryotherapy of the prostate for recurrent prostate cancer Patients who underwent radical prostatectomy as their primary therapy or other significant surgery (except prostatic biopsy) Patients with clinically confirmed distant metastasis (unless deemed beneficial by the treating physician) Any previous major rectal surgery Clinically significant lower urinary tract or rectal anomalies Existing urethral, rectal, or bladder fistulae</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Recurrent Prostate Cancer</keyword>
	<keyword>Prostate Cancer Recurrence</keyword>
	<keyword>Radiation Failure</keyword>
	<keyword>Salvage Cryotherapy</keyword>
</DOC>